Tongxinluo; low molecular heparin; unstable angina pectoris.
通心络；低分子肝素钙；不稳定型心绞痛。
The invention relates to a method for the base group modification of low molecular heparin.
本发明涉及一种低分子肝素的基团修饰方法。
Objective: To investigate the economics consequences of low molecular heparin in the treatment of UAP.
前言：目的：探讨三种低分子肝素钙治疗不稳定性心绞痛的经济效果。
Result: The effect of buflomedil group was better than ozagrel group and low molecular heparin calcium group.
结果：丁咯地尔组疗效较好，奥扎格雷组和低分子肝素钙组次之。
Objective: To explore the safety and efficiency of low molecular heparin calcium treating cerebral infarction.
目的：观察低分子肝素钙治疗脑梗死的有效性和安全性。
Objective To discuss the curative effect on heart failure treated with low molecular heparin (LMH) in pneumocardiac disease.
目的观察低分子肝素治疗肺原性心脏病肺心病心力衰竭的临床疗效。
Objective: To observe the curative effect of small dose low molecular heparin calcic in the treatment of diabetic nephropathy.
目的：观察小剂量低分子肝素钙治疗糖尿病肾病的疗效。
Objective: To discuss the relations between partially pressing hypodermic injection of low molecular heparin and partial hemorrhage.
目的：探讨皮下注射低分子肝素局部按压与否与局部出血的关系。
Objective To discuss the curative effect of the small dosage urokinase and the low molecular heparin calcium on cerebral infarction.
目的探讨小剂量尿激酶与低分子肝素钙治疗急性脑梗死的疗效。
Low molecular heparin has the features of high anticoagulation and less side effect of bleeding as compares with the ordinary heparin.
低分子肝素具有较高的抗凝作用，出血副作用较一般肝素明显减少。
Objective To evaluate the therapeutical effect of low molecular heparin calcium in the prevention of Henoch-Schonlein purpura nephritis (HSPN).
目的观察低分子肝素钙在预防小儿过敏性紫癜肾损害中的作用。
ObjectiveTo observe the combined effect and safety of Sodium Ozagrel and Low Molecular Heparin in the treatment of progressive cerebral infraction.
目的观察丹奥和低分子肝素联合治疗进展性脑梗死的疗效及安全性。
Objective To observe the curative effect on treatment of unstable angina with low molecular heparin calcium (LMHC) combined with Guanxinnin injection.
目的观察低分子肝素钙联合冠心宁治疗不稳定型心绞痛的临床疗效。
Objective to investigate the therapeutic effect of Shuxuening injection combined with low molecular heparin in treating of unstable angina pectoris (UAP).
目的观察舒血宁注射液联合低分子肝素治疗不稳定型心绞痛(uap)的临床疗效。
Objective To evaluate the effectivity of low molecular heparin calcium in treating Henoch-Schonlein purpura and preventing Henoch-Schonlein purpura nephritis(HSPN).
目的探讨低分子肝素钙治疗过敏性紫癜及预防紫癜性肾炎的作用。
Conclusion Yuri orlov klingenberg low molecular heparin calcium combined treatment can be used as the recent advances in the treatment of cerebral apoplexy one way.
结论尤瑞克林联合低分子肝素钙治疗可作为治疗进展性脑卒中的方法之一。
Objective To investigate the impact of low molecular heparin(LMH)and valsartan on urine albumin excretion rate(UAER)in patients with early type-2 diabetic nephropathy(DN).
目的观察低分子肝素联合缬沙坦对2型早期糖尿病肾病（DN）患者尿白蛋白排泄率（UAER）的影响。
Objective to know the effect of therapeutic alliance of low molecular heparin and sodium ferulate on unstable angina pectoris and improve the treatment effect of unstable angina pectoris.
目的了解低分子肝素与阿魏酸钠联合应用治疗不稳定型心绞痛的疗效，提高不稳定型心绞痛治疗效果。
The patient was diagnosed with DVT of the left leg, and low-molecular-weight heparin (nadroparin 0·4 mL, two times per day) was started, lasting 2 weeks.
病人诊断为左下肢DVT，并使用低分子肝素（那曲肝素0·4mL，一日两次）持续治疗两周。
Objective To observe the curative effect of low molecular weight heparin(LMWH) on the hypercoagulability in acute Kawasaki disease(KD).
目的观察低分子肝素（LMWH）治疗川崎病（KD）急性期血液高凝状态的临床疗效。
The immunocompetence of low molecular weight heparin(LMWH) derived from low anticoagulant activity heparin(LAAH), a by-product in commercial heparin production, was studied.
对比研究了低抗凝活性肝素、商品肝素及以低抗凝活性肝素为原料制得的低分子肝素的免疫活性。
Objective To evaluate the efficacy and safety of low-molecular-weight heparin(LMWH) in preventing for deep-vein thrombosis (DVT) after total hip replace(THR).
目的探讨人工髋关节置换术（THR）后用低分子肝素预防下肢深静脉血栓（DVT）形成的疗效和安全性。
Results: Both valsartan and low molecular weight heparin could significantly inhibit the proliferation of mesangial cells and when combined the effect was intensified.
结果：缬沙坦和低分子量肝素均可不同程度地抑制高糖刺激系膜细胞增殖，二者合用时作用增强。
Objective To investigate the effects of the combination of low molecular weight heparin and ACEI on albuminuria in diabetic nephropathy.
目的观察低分子肝素联合血管转换酶抑制剂对糖尿病肾病显性蛋白尿的治疗效果。
To observe the anticoagulation effect of low molecular weight heparin on hemodialysis and to study its related nursing aspect.
观察低分子量肝素在血液透析中的抗凝效果，比较与普通肝素在护理方面的不同处理。
AIM: To observe the clinical effect of combination therapy with ozagrel and low molecular weight heparin on progressive cerebral infarction.
目的：观察奥扎格雷钠、低分子肝素钠联合应用治疗进展性脑梗死的临床疗效。
When compared with each other, low-molecular-weight heparin was associated with a 32 percent reduced risk of deep vein thrombosis and a 53 percent lower rate of hematoma at the injection site.
当这两种肝素相比较时，低分子肝素能够减少32%的深静脉血栓和53%注射部位的血肿形成。
Conclusion Low molecular weight heparin combined with routine treatment can control angina pectoris and decrease the incidence of myocardial infarction more effectively.
结论在常规治疗基础上加用低分子肝素钠，能有效控制心绞痛发作，减少心肌梗死发生率。
Objective To observe the influence of low molecular weight heparin on cerebral blood flow and brain function in patients with acute cerebral infarction in different therapy time window.
目的研究不同时间窗低分子量肝素治疗急性脑梗死的疗效及其对患者脑血流量和脑电图的影响。
Objective To observe the influence of low molecular weight heparin on cerebral blood flow and brain function in patients with acute cerebral infarction in different therapy time window.
目的研究不同时间窗低分子量肝素治疗急性脑梗死的疗效及其对患者脑血流量和脑电图的影响。
应用推荐